Lung Fibrosis Affects One in Five Children With chILD
A European multicentre study reveals that pulmonary fibrosis affects about 20% of children with childhood interstitial lung disease (chILD), correlating with worse lung function and survival rates. The findings, based on data from 1,071 patients across 23 countries, emphasize the importance of early diagnosis and standardized criteria for targeted treatment.
Why it matters
This research provides critical epidemiological data on a rare and serious pediatric lung condition, informing clinical practice, guiding the development of diagnostic tools, and potentially improving outcomes for affected children through earlier intervention.
PULMONARY fibrosis affects approximately one in five children with childhood interstitial lung disease (chILD) and is associated with poorer lung function and survival, according to a European multicentre study.
The findings highlight the importance of recognising fibrosing disease in children with rare interstitial lung conditions and suggest that standardised diagnostic criteria could support earlier identification of patients who may benefit from targeted treatment.
Childhood interstitial lung disease encompasses a heterogeneous group of rare conditions affecting the lung tissue and surrounding structures.
Although pulmonary fibrosis is recognised as an important complication, its prevalence and relationship with long-term clinical outcomes have not previously been systematically established in large paediatric cohorts.
Researchers analysed data from the chILD-EU register, which includes children and adolescents from 23 European countries.
The prospective study examined 1,071 patients aged 0–18 years, with data collected between March 2004 and July 2025.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in